MILANO VINCENT

CIK 00011871597 companiesEXTON, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001187159

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-11-28$7.18/sh+783→ 91,219 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-08-29$8.31/sh+676→ 90,436 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-06-12+12,500→ 89,760 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2025-06-12+27,181→ 27,181 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 17,316 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-05-30$10.75/sh+523→ 77,260 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-02-28$8.61/sh+653→ 76,737 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-11-29$7.50/sh+750→ 76,084 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-08-30$8.69/sh+647→ 75,334 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-06-12+6,820→ 74,687 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 12,523 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-31$6.46/sh+870→ 67,867 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-20$6.25/sh+15,000→ 66,997 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-02-29$5.63/sh+999→ 51,997 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-11-30$5.88/sh+956→ 50,998 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-08-31$7.11/sh+791→ 50,042 total
Sale
Aceragen, Inc.
Common Stock
2023-08-10$0.53/sh−3,283→ 8,987 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-13+16,745→ 49,251 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 7,863 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-05-31$8.27/sh+680→ 32,506 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-02-28$8.85/sh+635→ 31,826 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-11-30$13.36/sh+421→ 31,191 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-08-31$13.90/sh+404→ 30,770 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-07-06+124,000→ 124,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-06-07+12,866→ 30,366 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 3,356 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-04-01+99,000→ 99,000 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2022-01-24+25,000→ 25,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-11-24$12.19/sh+7,500→ 17,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2021-07-26+66,667→ 66,667 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2021-07-08+124,000→ 124,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Sale
Aceragen, Inc.
Common Stock
2021-01-12$4.20/sh−3,210→ 208,611 total
Award
Aceragen, Inc.
Stock Option (Right to Buy)
2021-01-08+95,000→ 95,000 total

MILANO VINCENT

Recent Transactions

Companies

Recent Filings

Address